1. Home
  2. PRSO vs QNRX Comparison

PRSO vs QNRX Comparison

Compare PRSO & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRSO
  • QNRX
  • Stock Information
  • Founded
  • PRSO 2008
  • QNRX 2018
  • Country
  • PRSO United States
  • QNRX United States
  • Employees
  • PRSO N/A
  • QNRX 3
  • Industry
  • PRSO Semiconductors
  • QNRX Medical/Dental Instruments
  • Sector
  • PRSO Technology
  • QNRX Health Care
  • Exchange
  • PRSO Nasdaq
  • QNRX Nasdaq
  • Market Cap
  • PRSO 5.4M
  • QNRX 4.8M
  • IPO Year
  • PRSO 2001
  • QNRX N/A
  • Fundamental
  • Price
  • PRSO $1.15
  • QNRX $8.59
  • Analyst Decision
  • PRSO Strong Buy
  • QNRX
  • Analyst Count
  • PRSO 1
  • QNRX 0
  • Target Price
  • PRSO $3.00
  • QNRX N/A
  • AVG Volume (30 Days)
  • PRSO 10.3M
  • QNRX 107.3K
  • Earning Date
  • PRSO 11-11-2025
  • QNRX 11-06-2025
  • Dividend Yield
  • PRSO N/A
  • QNRX N/A
  • EPS Growth
  • PRSO N/A
  • QNRX N/A
  • EPS
  • PRSO N/A
  • QNRX N/A
  • Revenue
  • PRSO $13,608,000.00
  • QNRX N/A
  • Revenue This Year
  • PRSO N/A
  • QNRX N/A
  • Revenue Next Year
  • PRSO $47.61
  • QNRX N/A
  • P/E Ratio
  • PRSO N/A
  • QNRX N/A
  • Revenue Growth
  • PRSO 1.80
  • QNRX N/A
  • 52 Week Low
  • PRSO $0.52
  • QNRX $5.01
  • 52 Week High
  • PRSO $2.34
  • QNRX $54.95
  • Technical
  • Relative Strength Index (RSI)
  • PRSO 55.25
  • QNRX 70.88
  • Support Level
  • PRSO $1.18
  • QNRX $7.35
  • Resistance Level
  • PRSO $1.35
  • QNRX $7.79
  • Average True Range (ATR)
  • PRSO 0.15
  • QNRX 0.38
  • MACD
  • PRSO 0.02
  • QNRX 0.13
  • Stochastic Oscillator
  • PRSO 40.74
  • QNRX 46.79

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: